Purpose: To determine the intravisit and intervisit reproducibility of optical coherence tomography angiography measurements of macular vessel density in eyes with and without retinal diseases.
A n accurate and reliable method of quantifying retinal vascular perfusion could play an important role in the diagnosis and management of various retinal vascular diseases, including diabetic retinopathy, retinal artery or vein occlusions, and neovascular age-related macular degeneration. Fluorescein angiography and indocyanine green angiography have been clinically used to evaluate the retinal and choroidal vasculature in vivo. However, both these imaging methods are invasive and associated with a variety of complications including painful dye extravasation, inadvertent intraarterial injections, pruritus, nausea, temporary skin discoloration, and rarely but potentially catastrophic, anaphylactic reactions. 1, 2 In addition, dye-based angiography is not depth resolved, which means that the retinal and choroidal vasculatures cannot be resolved.
Optical coherence tomography angiography (OCTA) is a novel noninvasive imaging technology, which uses motion contrast to produce angiographic data across the retina and choroid. [3] [4] [5] [6] [7] [8] [9] [10] [11] The OCTA images provide high resolution of the capillary details and enable the ability to resolve superficial and deep retinal vascular networks separately. 11 Recent studies have shown that OCTA can be a useful tool in qualitative and quantitative assessment of retinal, choroidal, or optic nerve vessels in diabetic retinopathy, neovascular age-related macular degeneration, macular telangiectasia and glaucoma. [12] [13] [14] [15] [16] [17] [18] However, there is a paucity of data addressing the reproducibility of this technique. The current study sought to determine the intravisit and intervisit reproducibility of OCTA measurements of macular vessels in eyes with and without retinal diseases.
Methods
The study was approved by the institutional review board of University of California San Diego and complied with the Health Insurance Portability and Accountability Act of 1996, and the protocol adheres to the tenets of the Declaration of Helsinki. Written informed consent was obtained for each patient before enrollment into the study.
The commercially available Avanti spectral-domain OCT device (Optovue Inc, Fremont, CA) and the contained AngioVue OCTA system were used for imaging. This system used a split-spectrum amplitude decorrelation angiography software algorithm and acquired 70,000 A-scans per second to compose OCTA volumes consisting of 304 · 304 A-scans. Orthogonal registration and merging of 2 consecutive scans were used to obtain OCTA macula volume scans of a central 3 mm · 3 mm or 6 mm · 6 mm macula area of both eyes for each subject. 19, 20 Pupils of all the participants were dilated with 2.5% phenylephrine and 1.0% tropicamide to $6 mm in diameter. During imaging, the subject was instructed to fixate on an internal fixation target. Initial camera alignment, illumination, and focus were carried out in infrared mode and with assistance from the "Auto all" function of the machine. Only one randomly selected eye was scanned twice during the first and second testing visits. At each testing visit, the subject was asked to retract from the chin rest to have 1 minute or 2 minutes break after the first set of scans, and then reposition for the second set of scans to assess the intravisit reproducibility. The fellow eye was scanned only once in each session. The second visit took place approximately 2 weeks later, when the same scan protocol as the first visit was followed.
The OCTA image quality review was performed for all scans. Eighty-three of 351 scans (23.6%) with segmentation errors or with poor image quality because of motion, blur, and floaters were excluded. Scans with a Signal Strength Index .46 were included. The Signal Strength Index is a quantitative measure for image quality ranging from 1 (poor) to 100 (good). The threshold value 46 was chosen during the quality review before vessel density measurement. For included scans, the OCTA images of the superficial and deep capillary networks were generated separately using the automated software algorithm of the machine (ReVue, version 2014.2.0.65; Optovue Inc). Based on these default settings, the superficial network extends from 3 mm below the internal limiting membrane to 15 mm below the inner plexiform layer. The deep capillary network extends from 15 mm to 70 mm below the inner plexiform layer. The vessel density of the superficial and deep capillary network were measured and assessed separately with the embedded AngioVue software. The vessel density was defined as the proportion of vessel area with blood flow over the total area measured (Figures 1 and 2 ). Due to the projection artifacts from the superficial vessels, the accuracy of automated vessel density measurements in deep capillary network is limited, and was therefore excluded in the current study.
Statistical analyses were conducted using the R statistical software. Descriptive statistics included mean, standard deviation (SD), median, range, and percentages were presented where appropriate. Intravisit and intervisit reproducibility were summarized as coefficients of variation (CV) and intraclass correlation coefficients (ICCs). It is important to be cognizant that these two measurements, while estimating the same thing, have different properties; although the CV attempts to scale the variability for the measurement size to reduce the effect of measurement scaling in estimating reproducibility, ICCs measure the reproducibility of the measurement relative to true measurement differences between subjects (ie, if differences between subjects is low, the ICC will be reduced, but CV would be unaffected). Variance component models (a type of random effects model) were used to calculate the intravisit and intervisit variability of healthy and patient groups separately. Models were fitted with the vessel density measurement as a response with random effects for patient and visit to account for the interpatient and between-visit SDs, respectively. This effectively separated the total variance into three parts: with variance components due to visit, between-subject variability, and a residual variance component from "random" variability that cannot be ascribed to the former two components. The square root of the residual variance, or the residual SD was defined to be the intravisit SD, which represents the variability that would result from a single patient taking multiple tests in the same visit. The square root of the sum of the intravisit variance and the between-visit variance was defined to be the intervisit SD. Coefficients of variation were calculated by dividing the intravisit and intervisit SDs by the mean vessel density measurement; these statistics attempt to scale the variability according to the measurement size. The ICCs were also calculated as a summary of the intravisit and intervisit variability expressing the proportion of variance attributed to real differences (or disease status) between subjects. The ICCs were calculated by estimating the proportion of the total SD in measurements explained by actual measurement differences (i.e., the ratio of the intereye SDs and total SD). Large ICCs (close to 1) indicate that there are relatively small fluctuations between repeat measurements within an individual eye compared with variability between eyes. P-values represent results for two-sided tests, with values less than 0.05 considered statistically significant.
Results
Thirty-seven eyes of 37 persons were enrolled in the study, including 15 normal control eyes, 2 eyes with dry age-related macular degeneration, 2 eyes with central serous chorioretinopathy, 16 eyes with diabetic retinopathy without diabetic macular edema, 1 eye with myopic choroidal neovascularization, and 1 eye with macular telangiectasia Type II. Control normal eyes were recruited in persons without previous disease history and with best-corrected visual acuity $20/20, intraocular pressure $10 mmHg and #21 mmHg, without any abnormality found on dilated fundus examination and OCT scanning. No eyes included in the study received treatment, such as intravitreal injection or laser photocoagulation, during the study period. The mean age of the participants was 54 years (range: 37-68 years), and 57% of them were men. The demographic characteristics of the participants stratified by clinical diagnosis are summarized in Table 1 .
On 3 mm · 3-mm scans, the mean vessel densities in healthy eyes in the paracentral subfields and the whole area were significantly higher than the corresponding value of eyes with retinal diseases (Table  1) . On 6 mm · 6-mm scans, the mean vessel density of the superficial network in the normal control group was significantly higher than that of eyes with retinal diseases in all subfields ( Table 2) .
The CVs representing the intravisit reproducibility of the superficial macular vessel density measurements for different quadrants on 3 mm · 3-mm scans varied from 2.1% to 4.9% and 3.4% to 6.8% for healthy and diseased eyes, respectively, and for the intervisit it was 2.9% to 5.1% and 4.0% to 6.8%, respectively, showing a good intravisit and intervisit reproducibility (Table 3) .
In general, the CVs were lower in healthy eyes than in diseased eyes, showing a slightly better reproducibility in healthy eye compared with diseased eyes. Simultaneously, the CVs for intravisit were always lower than for intervisit, showing a slightly better intravisit repeatability than intervisit repeatability. In addition, the CVs on 3 mm · 3-mm scans tend to be slightly lower than 6 mm · 6-mm scans, showing a better repeatability of 3 mm · 3-mm scans than 6 mm · 6-mm scans (Table 3) .
For different subfield measurement, the central subfields in both healthy and diseased eyes had reduced reproducibility in terms of CV than the paracentral subfields. The intravisit CVs of the superficial macular vessel density measurement were 4.9% and 2.1% to 3.5% for central subfield and paracentral subfields, respectively, in healthy eyes on 3 mm · 3-mm scans, which were better (lower) than the corresponding data of 6.8% and 3.4% to 4.7%, respectively, in eyes with retinal diseases. Similarly, the intervisit CVs of the measurement were better (lower) in healthy eye than in eyes with retinal diseases (Table 3) .
The intravisit ICC for measurement of the whole macular area for controls and diseased eyes on 3 mm · 3-mm scans was 0.3 and 0.8, and on 6 mm · 6-mm scans it was 0.7 and 0.7, respectively. The intervisit ICC for the whole macular measurement for normal and diseased eyes was 0.3 and 0.8 on 3 mm · 3-mm scans and 0.5 and 0.6 on 6 mm · 6-mm scans, respectively. The ICCs tended to be substantially higher for eyes with retinal diseases than healthy eyes, both for the whole macular area measurement and for each subfields, likely reflecting greater variability in the range of macular vessel densities among eyes with retinal diseases. In addition, 3 mm · 3-mm scans tended to yield higher ICC measurements than corresponding 6 mm · 6-mm scans, particularly for diseased eyes (Table 4 ).
Discussion
The OCTA as a novel noninvasive imaging technology has enormous potential for assessing retinal vessels both in research and clinical settings. Assessment of its reproducibility is essential to determine its reliability for its application in clinical management and for research. The current study showed good intravisit and intervisit reproducibility for measurement of superficial macula vessel density, with most of the CVs lower than 5%. In addition, the reproducibility tended to be better in healthy subjects compared with patients with retinal diseases, better in paracentral area compared with central foveal area and better on 3 mm · 3-mm scans compared with 6 mm · 6-mm scans. The results also showed the superficial vessel density in eyes with retinal diseases (mostly nonproliferative diabetic retinopathy with mild or no macular edema) were lower compared with normal eyes.
The worse reproducibility for measurement of superficial vessel density in central foveal area compared with paracentral area might be related to the central foveal avascular zone (FAZ). Due to FAZ, the vessels only exist in periphery of the central measuring circle (Figure 1 ). Any mild change of the measuring circle center location will induce substantial variation on the vessel density value, which was defined as the proportion of vessel area with flowing blood over the total area measured. In addition, the FAZ size and/or shape, which varied individually, also influence the vessel density measurement for the central foveal region. However, the measurement of paracentral subfields would not be affected by the FAZ. And the FAZ has a less effect on the measurement of the whole macular area, for which the denominator is bigger than the central subfield. This result suggests that when assessing the macular vessel density, the measurement of paracentral area or the whole macular area is more reliable.
Quantitatively measuring the macular microcirculation is clinically important, as even mild microcirculation changes may lead to pathologic damage. 21 Small vessel changes have been demonstrated in multiple retinal vascular diseases, including, diabetic 25 The current study demonstrates that OCTA provides good reproducibility and is a reliable method for assessing macular microcirculation in superficial capillaries both in healthy eyes and eyes with retinal diseases. Good reproducibility and repeatability of FAZ measurements in superficial network layer in healthy subjects by OCTA has been recently reported. 26, 27 Carpineto et al 26 assessed 60 healthy eyes and reported the CVs of 1.83% (95% confidence interval, 1.51% to 2.20%) and 1.86% (95% confidence interval, 1.33% to 2.43%) for the first and second observers, respectively. Shahlaee et al 27 measured 17 healthy subjects and found interobserver agreement was high for all superficial FAZ measurements (ICC $ 0.90) but did not meet the lowest acceptable grader agreement for the deep vascular network (ICC , 0.85). Here, we showed that the intravisit and intervisit reproducibility of measuring the vessel density in the paracentral areas is better relative to the central foveal area.
There are several limitations of current study. First, the study was limited by only assessing the reproducibility of measurement of superficial network vessel density without analyzing the deep layer network. However, although the OCTA can image separately the superficial and deep capillary plexuses, the quantitative measurement of deep retinal vascular networks is limited by projection artifacts. 28 A recent study shows that in 68% of cases, the image of the superficial network variably superimposed on the deep capillary plexuses, interfering with its analysis. 29 Therefore, when doing quantitative analysis, focusing on the superficial network is technically more accurate. The second limitation of the current study is the relative small sample size and the difference in age between healthy controls and patients with retinal diseases. The evidence presented here demonstrates good reproducibility of OCTA for measurement of superficial macula vessel density in both healthy eyes and eyes with retinal diseases. In addition, reproducibility tends to be better in healthy subjects compared with patients with retinal diseases, better in parafoveal area compared with central foveal area, and intravisit reproducibility tended to be better than intervisit reproducibility.
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